The mechanism of cardioprotection by S-nitrosoglutathione monoethyl ester in rat isolated heart during cardioplegic ischaemic arrest

British Journal of Pharmacology

Volumn 119, Issue 3, 1996, Pages 511-518

  Konorev, Eugene A ^a   Joseph, Joy ^a   Tarpey, Margaret M ^b   Kalyanaraman, B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cyclic GMP; Electron spin resonance; Glycogen; Nitric oxide; Nitrosothiols

Indexed keywords

CARDIOPLEGIC AGENT; CYCLIC GMP; ESTER; GLUCOSE 6 PHOSPHATE; GLUTATHIONE DERIVATIVE; GLUTATHIONE ETHYL ESTER; GLYCOGEN; LACTIC ACID; MYOGLOBIN; NITRIC OXIDE; S NITROSOGLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; DRUG STRUCTURE; ELECTRON SPIN RESONANCE; GLYCOGEN ANALYSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029787905     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15701.x     Document Type: Article

References (57)

1. AHLNER, J., ANDERSSON, R.G.G., TORFGARD, K. & AXELSSON, K.L. (1991). Organic nitrate esters: clinical use and mechanism of action. Pharmacol. Rev., 43, 351-423.
2. ANDERSON, M.E., NAGANUMA, A., MEISTER, A. (1990). Protection against cisplatin toxicity by administration of glutathione ester. FASEB J., 4, 3251-3255.
3. ASTOR, M.B., ANDERSON, M.E. & MEISTER, A. (1988). Relationship between intracellular GSH levels and hypoxic cell radiosensitivity. Pharmacol. Ther., 39, 115-121.
4. BAKER, J.E., FELIX, C.C., OLINGER, G.N. & KALYANARAMAN, B. (1988). Myocardial ischaemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy. Proc. Natl. Acad. Sci. U.S.A., 85, 2786-2789.
5. BALLIGAND, J.-L., KELLY, R.A., MARSDEN, P.A., SMITH, T.W. & MICHEL, T. (1993). Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. U.S.A., 90, 347-351.
6. BARTEL, S., KARCZEWSKI, P. & KRAUSE, E.-G. (1993). Protein phosphorylation and cardiac function: cholinergic-adrenergic interactions. Cardiovasc. Res., 27, 1948-1953.
7. BARTEL, S., WILLENBROCK, R., HAASE, H., KARCZEWSKI, P., WALLUKAT, G., DIETZ, R. & KRAUSE, E.-G. (1995). Cyclic GMP-mediated phospholamban phosphorylation in intact cardiomyocytes. Biochem. Biophys. Res. Commun., 214, 75-80.
8. BEITNER, R., HABERMAN, S., CYCOWITZ, T. (1977). The effect of cyclic GMP on phosphofructokinase from rat tissues. Biochem. Biophys. Acta, 482, 330-340.
9. BERGMEYER, H.U. (1994). Methods of Enzymatic Analysis. New York: Academic.
10. CAMPBELL, E.A. & GRIFFITH, O.W. (1989). Glutathione monoethyl ester: HPLC analysis and direct preparation of free base form. Anal. Biochem., 183, 21-25.
11. CLEETER, M.W.G., COOPER, J.M., DARLEY-USMAR, V.M., MONCADA, S. & SCHAPIRA, A.H.V. (1994). Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett., 345, 50-54.
12. DE MEYER, G.R.Y., BULT, H., ÜSTÜNES, L., KOCKX, M.M., FEELISH, M. & HERMAN, A.G. (1995). Effect of nitric oxide donors as neointima formation and vascular reactivity in the collared carotid artery of rabbits. J. Cardiovasc. Pharmacol., 26, 272-279.
13. DEPRE, C. & HUE, L. (1994). Cyclic GMP in the perfused heart. Effect of ischaemia, anoxia, and nitric oxide synthase inhibitor. FEBS Lett., 345, 241-245.
14. DOELLER, J.E. & WITTENBERG, B.A. (1991). Myoglobin function and energy metabolism of isolated cardiac myocytes: effect of sodium nitrite. Am. J. Physiol., 261, H53-H62.
15. FEELISH, M. & NOACK, E.A. (1987). Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol., 139, 19-30.
16. GABOURY, J., WOODMAN, R.C., GRANGER, D.N., REINHARDT, P. & KUBES, P. (1993). Nitric oxide prevents leucocyte adherence: role of superoxide. Am. J. Physiol., 265, H862-H867.
17. GEVERS, W. (1988). Generation of protons by metabolic processes in heart cells. J. Mol. Cell. Cardiol., 9, 867-874.
18. GROVES, P.H., BANNING, A.P., PENNY, W.J., NEWBY, A.C., CHEADLE, H.A. & LEWIS, M.J. (1995). The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Cardiorasc. Res., 30, 87-96.
19. HARE, J.M., KEANEY, J.F., BALLIGAND, J.-L., LOSCALZO, J., SMITH, T.W. & COLUCCI, W.S. (1995). Role of nitric oxide in parasympathetic modulation of β-adrenergic myocardial contractility in normal dogs. J. Clin. Invest., 95, 360-366.
20. HART, T.W. (1985). Some observations concerning S-nitroso- and S-phenylsulfonyl-derivatives of L-cysteine and glutathione. Tetrahedron Lett., 26, 2013-2016.
21. HARTMAN, J.C., KURC, G.M., HULLINGER, T.G., WALL, T.M., SHEEHY, R.M. & SHEBUSKI, R.J. (1994). Inhibition of nitric oxide synthase prevents myocardial protection by Ramiprilat. J. Pharmacol. Exp. Ther., 270, 1071-1076.
22. 2+ current in single heart cells. Nature, 323, 273-275.
23. HASEBE, N., SHEN, Y-T. & VATNER, S.F. (1993). Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation, 88, 2862-2871.
24. 2, NO, and isocyanides. J. Am. Chem. Soc., 111, 380-387.
25. KONOREV, E.A., JOSEPH, J. & KALYANARAMAN, B. (1996). S-Nitrosoglutathione induces formation of nitrosylmyoglobin in isolated hearts during cardioplegic ischaemia - an electron spin resonance study. FEBS Lett., 378, 111-114.
26. KONOREV, E.A., TARPEY, M.M., JOSEPH, J., BAKER, J.E. & KALYANARAMAN, B. (1995a). Nitronyl nitroxides as probes to study the mechanism of vasodilatory action of nitrosavasodilators, nitrone spin traps, and nitroxides - role of nitric oxide. Free Rad. Biol. Med., 18, 169-177.
27. KONOREV, E.A., TARPEY, M.M., JOSEPH, J., BAKER, J.E. & KALYANARAMAN, B. (1995b). S-nitrosoglutathione improves functional recovery in the isolated rat heart after cardioplegic ischaemic arrest - evidence for a cardioprotective effect of nitric oxide. J. Pharmacol. Exp. Ther., 274, 200-206.
28. KUPRIYANOV, V.V., LAKOMKIN, V.L., STEINSCHNEIDER, A.Y., SEVERINA, M.Y., KAPELKO, V.I., RUUGE, E.K. & SAKS, V.A. (1988). Relationships between pre-ischaemic ATP and glycogen content and postischaemic recovery of rat heart. J. Mol. Cell. Cardiol., 20, 1151-1162.
29. KUROSE, W., KUBES, P., WOLF, R., ANDERSSON, D.C., PAULSEN, J., MRYASAKA, M. & GRANGER, D.N. (1993). Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ. Res., 73, 164-171.
30. LAUSTIOLA, K., VUORINEN, P., KARP, M., VAPAATALO, H. & METSÄ-KETELÄ, T. (1983). 8-bromo cyclic GMP inhibits NADH and lactate accumulation in hypoxic rat atria. Naunyn-Schmiedeberg's Arch. Pharmacol., 323, 361-363.
31. LJUSEGREN, M.E. & AXELSSON, K.L. (1993). Lactate accumulation in isolated hypoxic rat ventricular myocardium: effect of different modulators of the cyclic GMP system. Pharmacol. Toxicol., 72, 56-60.
32. MALYSHEV, I.Y.U., MANUKHINA, E.B., MIKOYAN, V.D., KUBRINA, L.N. & VANIN, A.F. (1995). Nitric oxide is involved in heat-induced HSP70 accumulation. FEBS Lett., 370, 159-162.
33. MARTENSSON, J. & MEISTER, A. (1989). Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester. Proc. Nat. Acad. Sci. U.S.A., 86, 471-475.
34. MATHEIS, G., SHERMAN, M.P., BUCKBERG, G.D., HAYBRON, D.M., YOUNG, H.H. & IGNARRO, L.J. (1992). Role of L-arginine - nitric oxide pathway in myocardial reoxygenation injury. Am. J. Physiol., 262, H616-H620.
35. MATHEWS, W.R. & KERR, S.W. (1993). Biological activity of S-nitrosothiols: the role of nitric oxide. J. Pharmacol. Exp. Ther., 267, 1529-1537.
36. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A., 88, 1197-1201.
37. NEELY, J.R. & GROTYOHANN, L.W. (1984). Role of glycolytic products in damage to ischaemic myocardium: dissociation of adenosine triphosphate levels and recovery of function of reperfused ischaemic hearts. Circ. Res., 55, 816-824.
38. NEELY, J.R. & MORGAN, H.E. (1974). Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann. Rev. Physiol., 36, 413-459.
39. PARK, J.-W., BILLMAN, G.E. & MEANS, G.E. (1993). Transnitrosation as a predominant mechanism in the hypotensive effect of S-nitrosogluathione. Biochem. Mol. Biol. Int., 30, 885-891.
40. PINSKY, D.J., OZ, M.C., KOGA, S., TAHA, Z., BROCKMAN, M.J., MARCUS, A.J., LIAO, H., NAKA, Y., BRETT, J., CANNON, P.J., NOWYGRAD, R., MALINSKI, T. & STERN, D. (1994). Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J. Clin. Invest., 93, 2291-2297.
41. RICHARD, V., BLANE, T., KAEFFER, N., TRON, C. & THUILLEZ, C. (1995). Myocardial and coronary endothelial protection effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide. Br. J. Pharmacol., 115, 1532-1538.
42. 2+-independent nitric oxide synthase in the myocardium. Br. J. Pharmacol., 105, 575-580.
43. SCHWEIZER, M. & RICHTER, C. (1994). Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem. Biophys. Res. Commun., 204, 169-175.
44. 2+ in intact cardiac myocytes. Circ. Res., 74, 970-978.
45. SHINOBU, L.A., JONES, S.G. & JONES, M.M. (1984). Sodium N-methyl D-glucamine dithiocarbamate and cadmium intoxication. Acta Pharmacol. Toxicol., 54, 189-194.
46. SIEGFREID, M.R., ERHARDT, J., RIDER, T., MA, X-L. & LEFER, A.M. (1992). Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischaemia-reperfusion. J. Pharmacol. Exp. Ther., 260, 668-675.
47. TOHSE, N. & SPERELAKIS, N. (1991). cGMP inhibits the activity of single calcium channels in embryonic chick heart cells. Circulation, 69, 325-331.
48. VANDEBROECK, A., UYTTENHOVE, K., BOLLEN, M. & STALMANS, W. (1988). The hepatic glycogenolysis induced by reversible ischaemia or KCN is exclusively catalyzed by phosphorylase a. Biochem. J., 256, 685-688.
49. VEGH, A., SZEKERES, L. & PARRATT, J. (1992). Preconditioning of ischaemic myocardium: involvement of the L-arginine nitric oxide pathway. Br. J. Pharmacol., 107, 648-652.
50. WAHLER, G.N. & DOLLINGER, S.J. (1995). Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am. J. Physiol., 268, C45-C54.
51. WHITE, R.L. & WITTENBERG, B.A. (1993). NADH fluorescence of isolated ventricular myocytes: effects of pacing, myoglobin, and oxygen supply. Biophys. J., 65, 196-204.
52. WILLIAMS, M.W., TAFT, C.S., RAMNAUTH, S., ZHAO, Z.-Q. & VINTEN-JOHANSEN, J. (1995). Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc. Res., 30, 79-86.
53. WOLFE, C.L., SIEVERS, R.E., VISSEREN, F.L.J. & DONNELLY, T.J. (1993). Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation, 87, 881-892.
54. WOOLFSON, R.G., PATEL, V.C., NEILD, G.H. & YELLON, D.M. (1995). Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation, 91, 1545-1551.
55. YANG, W., ANDO, J., KORENAZA, R., TOYO-OKA, T. & KAMIYA, A. (1994). Exogenous nitric oxide inhibits proliferation of cultured vascular endothelial cells. Biochem. Biophys. Res. Commun., 203, 1160-1167.
56. YAO, S.-K., AKHTAR, S., SCOTT-BURDEN, T., OBER, J.C., GOLINO, P., BUJA, L.M., CASSCELS, W. & WILLERSON, J.T. (1995). Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis. Circulation, 92, 1005-1010.
57. ZHU, P., ZAUGG, C.E., SIMPER, D., HORNSTEIN, P., ALLEGRINI, P.R. & BUSER, P.T. (1995). Bradykinin improves post-ischaemic recovery in the rat heart: role of high energy phosphates, nitric oxide, and prostacyclin. Cardiovasc. Res., 29, 658-663.